[{"Assets_0_Q2_USD":106908000.0,"CommonStockSharesOutstanding_0_Q2_shares":23117738.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-28838000.0,"NetIncomeLoss_2_Q2_USD":-24756000.0,"StockholdersEquity_0_Q2_USD":45693000.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180814"}]